In 2013, Wang et al. revealed that IGF-1 expression was significantly elevated in NSCLC compared with benign lung conditions, with its upregulation potentially accelerating the malignant transformation of LC cells, thereby enhancing their proliferative capacity.117. This evidence concerns the gene IGF1 and non-small cell lung carcinoma.